Hualan Bio sets dividend, renews auditor, revamps charter and plans expansion

Hualan Biological Engineering (SZSE: 002007) has announced a series of significant resolutions, including a dividend distribution, the reappointment of its auditor, proposed amendments to its charter, and updates on its strategic initiatives. The board recommends a cash dividend of RMB 2 per share, totaling RMB 365.76 million, subject to shareholder approval at the upcoming annual general meeting (AGM). The AGM, scheduled for April 25, will also address proposed amendments to the company's charter, reflecting a reduction in registered capital from RMB 1,828,780,926 to RMB 1,827,456,666, necessitated by a planned buyback and cancellation of 1,324,260 shares at RMB 10.59 per share as key performance targets for the 2023 incentive plan were unmet.